Thus, the inhibition of acetylcholinesterase, butyrylcholinesterase, tyrosinase, α-amylase, and α-glucosidase has been considered to mitigate the deleterious effects of type II diabetes and AD or as adjunctive treatment modalities [19]. This evidence concerns the gene ACHE and Alzheimer disease.